R&D

projects
Resultados del proyecto Mytitox
July 2, 2018

During the project, the synthesis of a COF (Covalent Organic Framework), capable of being used to capture toxins in the marine environment to predict toxic episodes, has been scaled.

Read More
projects
Resultados del proyecto NEOGALFARM
July 2, 2018

Ya están publicados los resultados del Proyecto NEOGALFARM, centrado en la búsqueda de nuevos fármacos para el tratamiento contra el cáncer mediante el desarrollo de terapias dirigidas a diferentes dianas terapéuticas y de tratamientos combinados. ¡Consúltalos aquí!

Read More
projects
Update on Mytitox project
May 11, 2018

New updates on Mytitox Project. All the information here!

Read More
Chemistry
GalChimia opens an R&D centre in the Barcelona Science Park
April 24, 2018

With this first subsidiary the Galicia-based company expects to increase its turnover by 25% over the next two years and step up its growth and internationalisation plan.

Read More
Discover the R&D projects in which Galchimia will focus in 2018
How is GalChimia’s R&D going?
February 8, 2018

Galchimia’s R&D activities in 2018 will focus on four projects: Nanofacturing, Biogreen, Neogalfarm and Mytitox.

Read More
GalChimia renews the accreditation for Crédit d’Impôt Recherche (CIR)
June 5, 2017

On 2014, the French government decided to provide the company with a 3 years accreditation for Crédit d’Impôt Recherche (CIR). Although,…

Read More
Are cars becoming more innovative than drugs?
December 12, 2014

For the first time in 10 years there is no pharmaceutical company among the three biggest R&D spenders! According to the…

Read More